1. Dendritic cell-based vaccine targeting aspartate-β-hydroxylas represents a promising therapeutic strategy for HCC
   Yujiao Zhou et al, 2019, Immunotherapy CrossRef
2. Development of a novel anti-human aspartyl-(asparaginyl) β-hydroxylase monoclonal antibody with diagnostic and therapeutic potential
   Ting Huyan et al, 2017, Oncology Letters CrossRef
3. Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target
   Noa G. Holtzman et al, 2021, Frontiers in Oncology CrossRef
4. Human aspartyl (asparaginyl) hydroxylase. A multifaceted enzyme with broad intra- and extra-cellular activity
   Jenna M Greve et al, 2021, Metallomics CrossRef
5. Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen
   Michael Babich et al, 2022, Heliyon CrossRef
6. Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway
   Qifei Zou et al, 2018, EBioMedicine CrossRef